Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-04

Clinical Trial Update: The Efficacy and Safety of Using Tranexamic Acid by Different Means to Reduce Blood Loss During Total Knee Replacement [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating different methods of tranexamic acid administration to reduce blood loss during total knee replacement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Xijing Hospital | Conditions: Blood Loss | Phase 4 | Status: COMPLETED